• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ixekizumab - Articles and news items


Lilly presents new data from the UNCOVER-2 trial of ixekizumab

Industry news / 8 March 2016 / Victoria White

In UNCOVER-2, patients with plaque psoriasis who did not respond to etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab…

Lilly’s ixekizumab demonstrates efficacy in psoriatic arthritis

Industry news / 10 November 2015 / Victoria White

Psoriatic arthritis patients treated with ixekizumab for 24 weeks achieved significant improvements in signs and symptoms of their disease compared to placebo…